Sponsor study identifier
observational
20
1 country
1
Study Start
May 1, 2018
Actual (reported)Primary Completion
January 1, 2021
Actual (reported)Study Completion
January 1, 2021
Actual (reported)Lung cancer is one of the most common cancers in the Singapore population, being the 2nd most commonly diagnosed cancer amongst males and 3rd most commonly diagnosed cancer amongst females. Pulmonologists, oncologists and thoracic surgeons are often consulted for the evaluation of imaging-identified pulmonary nodules. These may have been identified either incidentally or through screening. The majority of these are indeterminate and definitive investigation with biopsy or resection is invasive and not without risk. Hence, current consensus guidelines adopt a largely expectant strategy in the management of these indeterminate pulmonary nodules. There is substantial evidence that lung cancer in Asians may be unique with multiple driver mutations, lower age of presentation and may be independent of tobacco exposure. In addition, there are guidelines that recommend that the management of lung nodules in Asia should account for these differences. However, the evidence for alternative recommendations is lacking. The aim of the study will be to identify radiological and clinical predictors that can improve the diagnosis of lung nodules. These predictors may help build a model for lung nodule evaluation and surveillance. Prospective database of subjects meeting all of the following inclusion criteria to participate in this study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2018
Actual (reported)April 17, 2019
Actual (reported)April 22, 2019
Actual (reported)January 1, 2021
Actual (reported)January 1, 2021
Actual (reported)Histology
Malignant or benign
3 years
CT surveillance, Lung biopsy, Lung resection
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with lung nodules
Singhealth Institutions
Singapore, 169856, Singapore
20 participants (actual enrollment reported by the registry).
First Submitted
April 17, 2019
First Posted
April 22, 2019
Study Start
May 1, 2018
Actual (reported)ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
Contact the study team to confirm eligibility.
Primary Completion
January 1, 2021
Actual (reported)Study Completion
January 1, 2021
Actual (reported)Last Updated
October 1, 2021
Record last verified: 2021-09
No plan to share individual patient data
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: